VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
113 hedge funds and large institutions have $1.08B invested in Verona Pharma in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
19% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $1.55M
20% less capital invested
Capital invested by funds: $1.36B → $1.08B (-$270M)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
Holders
113
Holding in Top 10
7
Calls
$1.26M
Puts
$1.55M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$13M | |
| 3 | +$11.9M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$9.19M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.45M |
Top Sellers
| 1 | -$51M | |
| 2 | -$15.5M | |
| 3 | -$10.3M | |
| 4 |
Morgan Stanley
New York
|
-$10.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.67M |